<h3>涨幅榜</h3>
<ul>
<li><strong>Enliven Therapeutics</strong> (NASDAQ: ELVN) 股票在周四的常规交易中上涨了 42.3%，至 22.02 美元。该公司的市值为 9.181 亿美元。</li>
<li><strong>Century Therapeutics</strong> (NASDAQ: IPSC) 股票上涨了 40.46%，至 1.83 美元。其流通股的市场价值为 1.134 亿美元。</li>
<li><strong>Aclarion</strong> (NASDAQ: ACON) 股票上涨了 36.54%，至 7.85 美元。该公司的市值为 380 万美元。</li>
<li><strong>Neogen</strong> (NASDAQ: NEOG) 股票上涨了 31.68%，至 9.72 美元。其流通股的市场价值为 16 亿美元。该公司的第二季度财报今天发布。</li>
<li><strong>MoonLake</strong> (NASDAQ: MLTX) 股票上涨了 29.67%，至 14.64 美元。其流通股的市场价值为 7.998 亿美元。</li>
<li><strong>China SXT Pharmaceuticals</strong> (NASDAQ: SXTC) 股票上涨了 28.49%，至 2.57 美元。其流通股的市场价值为 2.32 亿美元。</li>
</ul>
<h3>跌幅榜</h3>
<ul>
<li><strong>Immuneering</strong> (NASDAQ: IMRX) 股票在周四的常规交易中下跌了 40.8%，至 4.93 美元。其流通股的市场价值为 5.378 亿美元。</li>
<li><strong>Cormedix</strong> (NASDAQ: CRMD) 股票下跌了 34.32%，至 7.34 美元。其流通股的市场价值为 8.8 亿美元。</li>
<li><strong>Acrivon Therapeutics</strong> (NASDAQ: ACRV) 股票下跌了 32.72%，至 1.99 美元。该公司的市值为 9300 万美元。</li>
<li><strong>Jasper Therapeutics</strong> (NASDAQ: JSPR) 股票下跌了 26.1%，至 1.51 美元。该公司的市值为 5730 万美元。</li>
<li><strong>Aspire Biopharma Hldgs</strong> (NASDAQ: ASBP) 股票下跌了 25.4%，至 0.09 美元。其流通股的市场价值为 1730 万美元。</li>
<li><strong>Bristol-Myers Squibb Company Celegne Contingent Value Rights</strong> (NYSE: CELGR) 股票下跌了 18.65%，至 0.09 美元。
<strong>另见：</strong> www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
<p>本文由 Benzinga 的自动内容引擎生成，并由编辑审核。</p>

IPSC

ELVN

<p>在周四的盘中交易中，Enliven Therapeutics (NASDAQ:ELVN) 以 42.3% 的涨幅领涨，股价达到 22.02 美元，其次是 Century Therapeutics (NASDAQ:IPSC) 上涨 40.46%，至 1.83 美元。其他显著的涨幅股票包括 Aclarion (NASDAQ:ACON) +36.54%，Neogen (NASDAQ:NEOG) +31.68%，以及 MoonLake (NASDAQ:MLTX) +29.67%。在下跌方面，Immuneering (NASDAQ:IMRX) 下跌 40.8%，至 4.93 美元，Cormedix (NASDAQ:CRMD) 下跌 34.32%，至 7.34 美元。Acrivon Therapeutics (NASDAQ:ACRV) 和 Jasper Therapeutics (NASDAQ:JSPR) 也出现了显著的下跌</p>

<h3>Gainers</h3>
<div class="lb-trans"><h3>涨幅榜</h3>
</div><ul>
<li><strong>Enliven Therapeutics</strong> (NASDAQ: ELVN) stock rose 42.3% to $22.02 during Thursday's regular session. The company's market cap stands at $918.1 million.</li>
<li><strong>Century Therapeutics</strong> (NASDAQ: IPSC) shares increased by 40.46% to $1.83. The market value of their outstanding shares is at $113.4 million.</li>
<li><strong>Aclarion</strong> (NASDAQ: ACON) shares rose 36.54% to $7.85. The company's market cap stands at $3.8 million.</li>
<li><strong>Neogen</strong> (NASDAQ: NEOG) stock increased by 31.68% to $9.72. The market value of their outstanding shares is at $1.6 billion. The company's, Q2 earnings came out today.</li>
<li><strong>MoonLake</strong> (NASDAQ: MLTX) shares rose 29.67% to $14.64. The market value of their outstanding shares is at $799.8 million.</li>
<li><strong>China SXT Pharmaceuticals</strong> (NASDAQ: SXTC) stock moved upwards by 28.49% to $2.57. The market value of their outstanding shares is at $232.0 million.</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>Enliven Therapeutics</strong> (NASDAQ: ELVN) 股票在周四的常规交易中上涨了 42.3%，至 22.02 美元。该公司的市值为 9.181 亿美元。</li>
<li><strong>Century Therapeutics</strong> (NASDAQ: IPSC) 股票上涨了 40.46%，至 1.83 美元。其流通股的市场价值为 1.134 亿美元。</li>
<li><strong>Aclarion</strong> (NASDAQ: ACON) 股票上涨了 36.54%，至 7.85 美元。该公司的市值为 380 万美元。</li>
<li><strong>Neogen</strong> (NASDAQ: NEOG) 股票上涨了 31.68%，至 9.72 美元。其流通股的市场价值为 16 亿美元。该公司的第二季度财报今天发布。</li>
<li><strong>MoonLake</strong> (NASDAQ: MLTX) 股票上涨了 29.67%，至 14.64 美元。其流通股的市场价值为 7.998 亿美元。</li>
<li><strong>China SXT Pharmaceuticals</strong> (NASDAQ: SXTC) 股票上涨了 28.49%，至 2.57 美元。其流通股的市场价值为 2.32 亿美元。</li>
</ul>
</div><h3>Losers</h3>
<div class="lb-trans"><h3>跌幅榜</h3>
</div><ul>
<li><strong>Immuneering</strong> (NASDAQ: IMRX) stock declined by 40.8% to $4.93 during Thursday's regular session. The market value of their outstanding shares is at $537.8 million.</li>
<li><strong>Cormedix</strong> (NASDAQ: CRMD) stock decreased by 34.32% to $7.34. The market value of their outstanding shares is at $880.0 million.</li>
<li><strong>Acrivon Therapeutics</strong> (NASDAQ: ACRV) stock fell 32.72% to $1.99. The company's market cap stands at $93.0 million.</li>
<li><strong>Jasper Therapeutics</strong> (NASDAQ: JSPR) stock declined by 26.1% to $1.51. The company's market cap stands at $57.3 million.</li>
<li><strong>Aspire Biopharma Hldgs</strong> (NASDAQ: ASBP) shares decreased by 25.4% to $0.09. The market value of their outstanding shares is at $17.3 million.</li>
<li><strong>Bristol-Myers Squibb Company Celegne Contingent Value Rights</strong> (NYSE: CELGR) stock decreased by 18.65% to $0.09.
<strong>See Also:</strong> www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>Immuneering</strong> (NASDAQ: IMRX) 股票在周四的常规交易中下跌了 40.8%，至 4.93 美元。其流通股的市场价值为 5.378 亿美元。</li>
<li><strong>Cormedix</strong> (NASDAQ: CRMD) 股票下跌了 34.32%，至 7.34 美元。其流通股的市场价值为 8.8 亿美元。</li>
<li><strong>Acrivon Therapeutics</strong> (NASDAQ: ACRV) 股票下跌了 32.72%，至 1.99 美元。该公司的市值为 9300 万美元。</li>
<li><strong>Jasper Therapeutics</strong> (NASDAQ: JSPR) 股票下跌了 26.1%，至 1.51 美元。该公司的市值为 5730 万美元。</li>
<li><strong>Aspire Biopharma Hldgs</strong> (NASDAQ: ASBP) 股票下跌了 25.4%，至 0.09 美元。其流通股的市场价值为 1730 万美元。</li>
<li><strong>Bristol-Myers Squibb Company Celegne Contingent Value Rights</strong> (NYSE: CELGR) 股票下跌了 18.65%，至 0.09 美元。
<strong>另见：</strong> www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
</div><p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>
<div class="lb-trans"><p>本文由 Benzinga 的自动内容引擎生成，并由编辑审核。</p>
</div>

12 只医疗保健股票在周四盘中交易中出现波动